Skip to Main Content

Paper Details

Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial.
Int J Radiat Oncol Biol Phys
8
2022

Datasets